|
MCID: MLN028
|
Melanoma, Malignant Sporadic malady |
|
Sources: 22MalaCards See all sources Export this MalaCard |
MalaCards: Melanoma, Malignant Sporadic, also known as melanoma, is related to melanoma and cutaneous malignant melanoma. An important gene associated with Melanoma, Malignant Sporadic is STK11 (serine/threonine kinase 11). The drugs carmustine and dacarbazine have been mentioned in the context of this disorder.
|
|
Sources: 33OMIM, 43UMLS See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for melanoma, malignant sporadic Drug clinical trials:Search ClinicalTrials for melanoma, malignant sporadic Search NIH Clinical Center for melanoma, malignant sporadic Search CenterWatch for melanoma, malignant sporadic Inferred drug relations via UMLS/NDF-RT:43 28 aldesleukin, bleomycin, bleomycin sulfate, carmustine, dacarbazine, dactinomycin, docetaxel, hydroxyurea, interferon, interferon alfa 2-b, interferon alfa-2a, interferon alfa-2a,recombinant, interferon alfa-2b, interferon alfa-2b,recombinant, interferon alfa-3n,human leukocyte derived, interferon alfacon-1, interferon beta-1a,recombinant, interferon beta-1b,recombinant, interferon gamma-1b, lomustine, peginterferon alfa-2a, peginterferon alfa-2b, procarbazine, procarbazine hydrochloride, temozolomide |
|
|
|
|
|
|
|
|
|
Sources: 1BioGPS See all sources |
![]() |
|
|
|
|
|
|
